Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ken Bergquist"'
Autor:
Bryce B. Reeve, Larry Michael, Joy A. Peter, Paul W. Stewart, Anna S.-F. Lok, Meichen Dong, Ken Bergquist, David R. Nelson, Donna M. Evon
Publikováno v:
GastroHep. 2022:1-9
Background. Despite high efficacy rates for direct acting antiviral regimens to cure hepatitis C virus infection, many patients experience treatment-related symptoms. Accurate reporting of adverse events is mandatory to determine drug safety. Previou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75fad9530ee306cb5d7e5b5bfa70fa28
https://doi.org/10.1155/2022/2673911
https://doi.org/10.1155/2022/2673911
Autor:
Joy Peter, Larry Michael, Rakesh Tripathi, Gurjit S. Sidhu, Ryan Tamashiro, Lois Larsen, Gary P. Wang, Jens Kort, David R. Nelson, Gretja Schnell, Joan A. Whitlock, Michael W. Fried, Layla Schuster, Ken Bergquist, Chandni B. Patel, Ashley Magee
Publikováno v:
Journal of Hepatology. 75:820-828
Background & Aims Retreatment with glecaprevir/pibrentasvir (G/P) resulted in a rate of sustained virologic response 12 weeks after treatment completion (SVR12) of >90% in HCV genotype 1 (GT1) patients who previously failed a regimen of sofosbuvir pl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9e227d95ff0ba790d06dc670f9ea9ce
https://doi.org/10.1016/j.jhep.2021.04.057
https://doi.org/10.1016/j.jhep.2021.04.057